ELOVL6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.423360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.298600E-01
Normal-vs-Stage2
1.198190E-01
Normal-vs-Stage3
1.840990E-01
Normal-vs-Stage4
1.840840E-01
Stage1-vs-Stage2
9.015400E-01
Stage1-vs-Stage3
7.032800E-01
Stage1-vs-Stage4
6.207200E-01
Stage2-vs-Stage3
5.630200E-01
Stage2-vs-Stage4
4.862600E-01
Stage3-vs-Stage4
4.455800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.644020E-01
Normal-vs-AfricanAmerican
6.936100E-02
Normal-vs-Asian
1.117990E-01
Caucasian-vs-AfricanAmerican
7.960800E-01
Caucasian-vs-Asian
5.705800E-01
AfricanAmerican-vs-Asian
8.781400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.791960E-01
Normal-vs-Female
9.574300E-02
Male-vs-Female
5.722800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.074600E-01
Normal-vs-Age(41-60Yrs)
1.058020E-01
Normal-vs-Age(61-80Yrs)
1.181620E-01
Normal-vs-Age(81-100Yrs)
8.058200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.824200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.407200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.857800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.917700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.584200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.276400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.028200E-01
Normal-vs-Daily Drinker
1.044210E-02
Normal-vs-Weekly Drinker
1.362400E-01
Normal-vs-Occasional Drinker
1.325650E-01
Normal-vs-Social Drinker
1.919160E-01
Non Drinker-vs-Daily Drinker
8.783800E-01
Non Drinker-vs-Weekly Drinker
1.615390E-01
Non Drinker-vs-Occasional Drinker
6.740200E-01
Non Drinker-vs-Social Drinker
9.229600E-01
Daily Drinker-vs-Weekly Drinker
2.291000E-01
Daily Drinker-vs-Occasional Drinker
8.358000E-01
Daily Drinker-vs-Social Drinker
8.377400E-01
Weekly Drinker-vs-Occasional Drinker
9.725900E-02
Weekly Drinker-vs-Social Drinker
2.881400E-01
Occasional Drinker-vs-Social Drinker
6.386400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.808200E-01
Normal-vs-Grade 2
1.483350E-01
Normal-vs-Grade 3
1.236570E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.100560E-01
Grade 1-vs-Grade 3
9.680100E-02
Grade 1-vs-Grade 4
3.808200E-01
Grade 2-vs-Grade 3
7.559200E-01
Grade 2-vs-Grade 4
1.483350E-01
Grade 3-vs-Grade 4
1.236570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.896440E-01
Normal-vs-NonDiabetic
1.419790E-01
Diabetic-vs-NonDiabetic
1.607760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.267010E-01
Normal-vs-NoPancreatitis
1.708410E-01
Pancreatitis-vs-NoPancreatitis
6.375800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.218770E-01
Normal-vs-N1
1.476040E-01
N0-vs-N1
5.843000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.12590000048252E-07
Normal-vs-TP53-NonMutant
1.026710E-04
TP53-Mutant-vs-TP53-NonMutant
1.682080E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
